Quarterly Update and Appendix 4C
Filed with ASX · · 13 pages · English
Summary by 6ix AI
The company reported a notable increase in contracted licenses and revenue, alongside successful pilot programs in Canada and the UK. PainChek also achieved ISO certification, enhancing its commitment to information security and data protection. The CEO emphasized strong growth and the potential for further expansion in both local and international markets.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from PainChek
- Response to ASX Price Query
- PainChek A$3.55m Placement
- US nursing home study to pave way for FDA De Novo clearance
- PainChek receives $1.049m R&D Tax Incentive Refund
- Ethos Laboratories Distribution Agreement
Later from PainChek
- Notice of Acceptance for European Patent
- Underwritten Share Purchase Plan to raise AUD $2.5 million
- PainChek Share Purchase Plan oversubscribed
- PainChek completes A$5m capital raise
- PainChek UK partnership with Nourish Care
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek